Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study

Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study

This study analyzes an oral supplement of molecular iodine (I<sub>2</sub>), alone and in combination with the neoadjuvant therapy 5-fluorouracil/epirubicin/cyclophosphamide or taxotere/epirubicin (FEC/TE) in women with Early (stage II) and Advanced (stage III) breast cancer. In the Early...

Full description

Bibliographic Details
Main Authors: Aura Moreno-Vega, Laura Vega-Riveroll, Tonatiuh Ayala, Guillermo Peralta, José Miguel Torres-Martel, Joel Rojas, Perla Mondragón, Adriana Domínguez, Rodrigo De Obaldía, Carlos Avecilla-Guerrero, Brenda Anguiano, Evangelina Delgado-González, Xóchitl Zambrano-Estrada, Olga Cuenca-Micó, Olivia De La Puente Flores, Alfredo Varela-Echavarría, Carmen Aceves
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Nutrients
Subjects:
molecular iodine
breast cancer
chemoresistance
immune response
transcriptomic analysis
Online Access:https://www.mdpi.com/2072-6643/11/7/1623

Internet

https://www.mdpi.com/2072-6643/11/7/1623

Similar Items